Weight loss medication options: We only feature FDA-approved weight loss medications
CrossRef Hepatoprotective effects of the branched-chain fatty acids 12-methylmyristic and 13-methylmyristic against palmitate-induced lipotoxicity Sara Rico-Chazarra, Carmen Garca-Melgares, Inmaculada Ros-Madrid, Mara A
Primary outcomes were maternal weight change (enrolment to 36 weeks) and offspring standardised birthweight
Albers JW, Chaudhry V, Cavaletti G, Donehower RC
Blood work during this phase should be more frequent than during maintenance
Retatrutide represents one example of this shift toward precision metabolic modulation, where therapies address appetite, insulin resistance, energy expenditure, and fat metabolism together